BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abd-Aziz N, Poh CL. Development of oncolytic viruses for cancer therapy. Transl Res 2021:S1931-5244(21)00104-3. [PMID: 33905949 DOI: 10.1016/j.trsl.2021.04.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ahmed T. Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme. MedComm – Oncology 2023;2. [DOI: 10.1002/mog2.23] [Reference Citation Analysis]
2 Darabi N, Keshavarz M, Nabipour I, Assadi M. The sodium iodide symporter (NIS) as theranostic gene: potential role in pre-clinical therapy of extra-thyroidal malignancies. Clin Transl Imaging 2023. [DOI: 10.1007/s40336-023-00540-0] [Reference Citation Analysis]
3 Su Y, Su C, Qin L. Current landscape and perspective of oncolytic viruses and their combination therapies. Transl Oncol 2022;25:101530. [PMID: 36095879 DOI: 10.1016/j.tranon.2022.101530] [Reference Citation Analysis]
4 Xinyi Zhang, Hengqing Cui, Wenjun Zhang, Zhaoshen Li, Jie Gao. Engineered tumor cell-derived vaccines against cancer: The art of combating poison with poison. Bioact Mater 2022;22. [PMID: 36330160 DOI: 10.1016/j.bioactmat.2022.10.016] [Reference Citation Analysis]
5 Wang H, Shi F, Zheng S, Zhao M, Pan Z, Xiong L, Zheng L. Feasibility of hepatocellular carcinoma treatment based on the tumor microenvironment. Front Oncol 2022;12:896662. [DOI: 10.3389/fonc.2022.896662] [Reference Citation Analysis]
6 Sabit H, Abdel-hakeem M, Shoala T, Abdel-ghany S, Abdel-latif MM, Almulhim J, Mansy M. Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs. Pharmaceutics 2022;14:1566. [DOI: 10.3390/pharmaceutics14081566] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Gentile P. Breast Cancer Therapy: The Potential Role of Mesenchymal Stem Cells in Translational Biomedical Research. Biomedicines 2022;10:1179. [DOI: 10.3390/biomedicines10051179] [Reference Citation Analysis]
8 Zhang C, Fang L, Wang X, Yuan S, Li W, Tian W, Chen J, Zhang Q, Zhang Y, Zhang Q, Zheng J. Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma. Mol Ther Oncolytics 2022;24:14-25. [PMID: 34977339 DOI: 10.1016/j.omto.2021.11.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
9 Huang Y, Li X, Chen W, He Y, Wu S, Li X, Hou B, Wang S, He Y, Jiang H, Lun Y, Zhang J. Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma. Int Immunopharmacol 2021;101:108286. [PMID: 34735975 DOI: 10.1016/j.intimp.2021.108286] [Reference Citation Analysis]